Rocket Pharmaceuticals Inc (RCKT)
13.98
-0.84
(-5.67%)
USD |
NASDAQ |
Nov 15, 16:00
14.06
+0.08
(+0.57%)
After-Hours: 20:00
Rocket Pharmaceuticals Market Cap: 1.274B for Nov. 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 15, 2024 | 1.274B |
| November 14, 2024 | 1.351B |
| November 13, 2024 | 1.428B |
| November 12, 2024 | 1.461B |
| November 11, 2024 | 1.537B |
| November 08, 2024 | 1.591B |
| November 07, 2024 | 1.572B |
| November 06, 2024 | 1.603B |
| November 05, 2024 | 1.567B |
| November 04, 2024 | 1.533B |
| November 01, 2024 | 1.547B |
| October 31, 2024 | 1.517B |
| October 30, 2024 | 1.546B |
| October 29, 2024 | 1.581B |
| October 28, 2024 | 1.594B |
| October 25, 2024 | 1.553B |
| October 24, 2024 | 1.569B |
| October 23, 2024 | 1.603B |
| October 22, 2024 | 1.613B |
| October 21, 2024 | 1.605B |
| October 18, 2024 | 1.715B |
| October 17, 2024 | 1.679B |
| October 16, 2024 | 1.646B |
| October 15, 2024 | 1.520B |
| October 14, 2024 | 1.540B |
| Date | Value |
|---|---|
| October 11, 2024 | 1.559B |
| October 10, 2024 | 1.508B |
| October 09, 2024 | 1.515B |
| October 08, 2024 | 1.572B |
| October 07, 2024 | 1.528B |
| October 04, 2024 | 1.495B |
| October 03, 2024 | 1.463B |
| October 02, 2024 | 1.545B |
| October 01, 2024 | 1.560B |
| September 30, 2024 | 1.683B |
| September 27, 2024 | 1.679B |
| September 26, 2024 | 1.601B |
| September 25, 2024 | 1.679B |
| September 24, 2024 | 1.664B |
| September 23, 2024 | 1.800B |
| September 20, 2024 | 1.835B |
| September 19, 2024 | 1.943B |
| September 18, 2024 | 1.896B |
| September 17, 2024 | 1.983B |
| September 16, 2024 | 1.747B |
| September 13, 2024 | 1.788B |
| September 12, 2024 | 1.723B |
| September 11, 2024 | 1.731B |
| September 10, 2024 | 1.782B |
| September 09, 2024 | 1.795B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
524.07M
Minimum
May 11 2022
4.020B
Maximum
Feb 08 2021
1.723B
Average
1.574B
Median
Oct 12 2023
Market Cap Benchmarks
| Apellis Pharmaceuticals Inc | 3.268B |
| NovaBay Pharmaceuticals Inc | 3.482M |
| Palatin Technologies Inc | 18.26M |
| iBio Inc | 19.69M |
| Theriva Biologics Inc | 1.367M |
Market Cap Related Metrics
| Price to Book Value | 3.864 |
| Price | 13.98 |
| Earnings Yield | -19.67% |